F Poccia1, M Malkovsky, A Pollak, V Colizzi, G Sireci, A Salerno, F Dieli. 1. Department of Medical Microbiology and Immunology, University of Wisconsin Medical School, University of Wisconsin Comprehensive Cancer Center, and Wisconsin Regional Primate Research Center, Madison, Wisconsin 53706, USA.
Abstract
BACKGROUND: The recognition of phosphorylated nonpeptidic microbial metabolites by Vgamma9Vdelta2 T cells does not appear to require the presence of MHC molecules or antigen processing, permitting rapid responses against microbial pathogens. These may constitute an important area of natural anti-infectious immunity. To provide evidence of their involvement in immune reactivities against mycobacteria, we measured the responsiveness of peripheral blood Vgamma9Vdelta2 T cells in children with primary Mycobacterium tuberculosis (MTB) infections. MATERIALS AND METHODS: Peripheral blood mononuclear cells from 22 children with MTB infections and 16 positivity of tuberculin (PPD)-negative healthy children were exposed to nonpeptidic antigens in vitro and the reactivity of the Vgamma9Vdelta2 T cell subset with these antigens was determined using proliferation and cytokine assays. Also, responses of gammadelta T cells from rhesus monkeys stimulated with phosphoantigens in vivo were measured. RESULTS: The Vgamma9Vdelta2 T cell responses were highly increased in infected children in comparison with age-matched controls. This augmented Vgamma9Vdelta2 T cell reactivity subsided after successful antibiotic chemotherapy, suggesting that persistent exposure to mycobacterial antigens is required for the maintenance of gammadelta T cell activation in vivo. The in vivo reactivity of Vgamma9Vdelta2 T cells to phosphoantigens was also analyzed in a rhesus monkey model system. Intravenous injections of phosphoantigens induced an activated state of simian Vgamma9Vdelta2 T cells which decreased after 2 months, i.e., with a time course similar to that seen in MTB-infected children. CONCLUSIONS: The increased reactivity of Vgamma9Vdelta2 T cells to phosphoantigens appears to be dependent on constant antigenic exposure. Consequently, the assessment of Vgamma9Vdelta2 responses may be useful for monitoring the efficacy of antimycobacterial therapies.
BACKGROUND: The recognition of phosphorylated nonpeptidic microbial metabolites by Vgamma9Vdelta2 T cells does not appear to require the presence of MHC molecules or antigen processing, permitting rapid responses against microbial pathogens. These may constitute an important area of natural anti-infectious immunity. To provide evidence of their involvement in immune reactivities against mycobacteria, we measured the responsiveness of peripheral blood Vgamma9Vdelta2 T cells in children with primary Mycobacterium tuberculosis (MTB) infections. MATERIALS AND METHODS: Peripheral blood mononuclear cells from 22 children with MTB infections and 16 positivity of tuberculin (PPD)-negative healthy children were exposed to nonpeptidic antigens in vitro and the reactivity of the Vgamma9Vdelta2 T cell subset with these antigens was determined using proliferation and cytokine assays. Also, responses of gammadelta T cells from rhesus monkeys stimulated with phosphoantigens in vivo were measured. RESULTS: The Vgamma9Vdelta2 T cell responses were highly increased in infected children in comparison with age-matched controls. This augmented Vgamma9Vdelta2 T cell reactivity subsided after successful antibiotic chemotherapy, suggesting that persistent exposure to mycobacterial antigens is required for the maintenance of gammadelta T cell activation in vivo. The in vivo reactivity of Vgamma9Vdelta2 T cells to phosphoantigens was also analyzed in a rhesus monkey model system. Intravenous injections of phosphoantigens induced an activated state of simian Vgamma9Vdelta2 T cells which decreased after 2 months, i.e., with a time course similar to that seen in MTB-infected children. CONCLUSIONS: The increased reactivity of Vgamma9Vdelta2 T cells to phosphoantigens appears to be dependent on constant antigenic exposure. Consequently, the assessment of Vgamma9Vdelta2 responses may be useful for monitoring the efficacy of antimycobacterial therapies.
Authors: M B Brenner; J McLean; H Scheft; J Riberdy; S L Ang; J G Seidman; P Devlin; M S Krangel Journal: Nature Date: 1987 Feb 19-25 Impact factor: 49.962
Authors: F Lang; M A Peyrat; P Constant; F Davodeau; J David-Ameline; Y Poquet; H Vié; J J Fournié; M Bonneville Journal: J Immunol Date: 1995-06-01 Impact factor: 5.422
Authors: P Fisch; M Malkovsky; S Kovats; E Sturm; E Braakman; B S Klein; S D Voss; L W Morrissey; R DeMars; W J Welch Journal: Science Date: 1990-11-30 Impact factor: 47.728
Authors: C M Parker; V Groh; H Band; S A Porcelli; C Morita; M Fabbi; D Glass; J L Strominger; M B Brenner Journal: J Exp Med Date: 1990-05-01 Impact factor: 14.307
Authors: Andrew M Hebbeler; Cristiana Cairo; Jean Saville Cummings; C David Pauza Journal: Cancer Immunol Immunother Date: 2006-11-28 Impact factor: 6.968
Authors: J A Langermans; P Andersen; D van Soolingen; R A Vervenne; P A Frost; T van der Laan; L A van Pinxteren; J van den Hombergh; S Kroon; I Peekel; S Florquin; A W Thomas Journal: Proc Natl Acad Sci U S A Date: 2001-09-18 Impact factor: 11.205
Authors: Michael D Welsh; Hilary E Kennedy; Allister J Smyth; R Martyn Girvin; Peter Andersen; John M Pollock Journal: Infect Immun Date: 2002-11 Impact factor: 3.441
Authors: Arati B Kamath; Lisheng Wang; Hiranmoy Das; Lin Li; Vernon N Reinhold; Jack F Bukowski Journal: Proc Natl Acad Sci U S A Date: 2003-04-28 Impact factor: 11.205
Authors: Mei Xia; Danny C Hesser; Prithwiraj De; Isaac G Sakala; Charles T Spencer; Jay S Kirkwood; Getahun Abate; Delphi Chatterjee; Karen M Dobos; Daniel F Hoft Journal: Infect Immun Date: 2016-08-19 Impact factor: 3.441
Authors: Pádraic J Dunne; Christina O Maher; Michael Freeley; Katie Dunne; Andreea Petrasca; Judy Orikiiriza; Margaret R Dunne; Derval Reidy; Siobhan O'Dea; Aisling Loy; Jim Woo; Aideen Long; Thomas R Rogers; Fiona Mulcahy; Derek G Doherty Journal: Front Immunol Date: 2018-05-02 Impact factor: 7.561